Study finds lab-created antibody effective in preventing severe respiratory illness in infants

NEW DELHI: (May 2) A monoclonal antibody — a protein created in a lab which mimics the work of a natural antibody — could be highly effective in preventing severe RSV, a respiratory infection and major cause of serious illness in infants, according to a research.

Findings of the study, published in The Lancet Child and Adolescent Health journal, show that injecting infants with the antibody ‘nirsevimab’ reduces risk of RSV-related hospitalisations by 83 per cent and intensive care admissions by 81 per cent.

Infant immunisation programmes could, therefore, help address the health and economic burden due to RSV in the high-risk period following birth, a team of researchers from Canada and the US said.

Source: PTI News

Digitalmitra